IGM Biosciences | DEF 14A: Definitive information statements
Apr 26 16:34 ET
IGM Biosciences | DEFA14A: Others
Apr 26 16:18 ET
IGM Biosciences | 8-K: Current report
Apr 17 08:39 ET
IGM Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 15 09:04 ET
IGM Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 7 16:32 ET
IGM Biosciences | 8-K: IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mar 7 16:17 ET
IGM Biosciences | 8-K: Current report
Jan 8 00:00 ET
IGM Biosciences | 8-K: Current report
Dec 8, 2023 16:05 ET
IGM Biosciences | S-3: Registration statement for specified transactions by certain issuers
Nov 13, 2023 17:08 ET
IGM Biosciences | 8-K: IGM Biosciences Announces Third Quarter 2023 Financial Results
Nov 13, 2023 16:10 ET
IGM Biosciences | 8-K: Current report
Oct 3, 2023 16:14 ET
IGM Biosciences | 8-K: IGM Biosciences Announces Second Quarter 2023 Financial Results
Aug 3, 2023 16:13 ET
IGM Biosciences | 8-K: Current report
Jun 27, 2023 17:05 ET
IGM Biosciences | 8-K: Current report
Jun 23, 2023 16:41 ET
IGM Biosciences | 8-K: Current report
Jun 21, 2023 16:59 ET
IGM Biosciences | 8-K: IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 12, 2023 09:06 ET
IGM Biosciences | DEFA14A: Others
Apr 27, 2023 16:32 ET
IGM Biosciences | DEF 14A: Definitive proxy statements
Apr 27, 2023 16:30 ET
IGM Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 30, 2023 16:11 ET
IGM Biosciences | 8-K: IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Mar 30, 2023 16:06 ET
No Data
No Data